Devices & Diagnostics

Technology for minimally invasive surgery of tear drainage system secures $1.2 million

A stealth-mode Colorado startup is raising $2.4 million for the development of a minimally invasive technique for the lacrimal (tear drainage) system.

Company name: Sinopsys Surgical, also known as DCS Surgical Inc.

Industry: Medical devices (surgery).

Location: Boulder, Colorado.

Solution/product: Currently in stealth mode, the company is developing minimally invasive surgical technology for the lacrimal system, which comprises structures for tear production and drainage.

Money raised: Half of a $2.4 million equity offering.

Investors: The U.S. Securities and Exchange Commission filing lists directors from DFJ Mercury, High Country Venture and Aweida Venture Partners.

Management team: CEO Harry Ross is a former partner at Aweida Venture Partners.

Competitors: Quest Medical, FCI Ophthalmics and Sterimedix also make devices for blocked tear ducts.